Gastric cancer is a rare outcome of chronic Helicobacter
pylori infection. Serologic profiles may reveal bacterial,
environmental and/or host factors associated with cancer risk. We therefore
compared specific anti-H. pylori antibodies among populations
with at least 2-fold differences in gastric cancer mortality from Mexico,
Colombia and Chile. Our study included 1,776 adults (mean age 42 years) from
three nationally representative surveys, equally divided between residents of
high- and low-risk areas. Antibodies to 15 immunogenic H.
pylori antigens were measured by fluorescent bead-based multiplex
assays; results were summarized to identify overall H. pylori
seropositivity. We used logistic regression to model associations between
antibody seroreactivity and regional cancer risk (high vs.
low), adjusting for country, age and sex. Both risk areas had similar H.
pylori seroprevalence. Residents in high- and low-risk areas were
seroreactive to a similar number of antigens (means 8.2 vs.
7.9, respectively; adjusted-odds ratio, OR: 1.02, p=0.05).
Seroreactivities to Catalase and the known virulence proteins CagA and VacA were
each significantly (p<0.05) associated with residence in high-risk areas, but
ORs were moderate (1.26, 1.42, and 1.41, respectively) and their discriminatory
power was low (ROC area under curve <0.6). The association of Catalase was
independent from effects of either CagA or VacA. Sensitivity analyses for
antibody associations restricted to H. pylori-seropositive
individuals generally replicated significant associations. Our findings suggest
that humoral responses to H. pylori are insufficient to
distinguish high and low gastric cancer risk in Latin America. Factors
determining population variation of gastric cancer burden remain to be
identified.